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ELECTROPHYSIOLOGIC STUDIES
Use of Electrophysiologic Testing in Patients With Nonsustained
Ventricular Tachycardia   Prognostic and Therapeutic Implications
RICHARD C. KLEIN, MD, FACC, CHARLES MACHELL, MD
Albuquerque, New Mexico
Forty patients with coronary artery disease and nonsus-
tained ventricular tachycardia on ambulatory electrocar-
diographic monitoring underwent programmed electrical
stimulation . In 22 patients, monomorphic ventricular
tachycardia was induced at baseline drug-free electrophys-
iologic testing ;   of these patients subsequently developed a
clinical sustained ventricular tachyarrhythmia . In 18 pa-
tients, no tachycardia could be induced, and none of these
18 had subsequent tachycardia .
In 25 of the 40 patients, arrhythmia management was
guided by the results of electrophysiologic testing ; this
group included 11 patients who received antiarrhythmic
therapy for induced ventricular tachycardia and 14 patients
without inducible ventricular tachycardia who did not
The presence of nonsustained ventricular tachycardia on
ambulatory electrocardiographic (ECG) monitoring has been
associated with an increased incidence of subsequent sus-
tained tachycardia and sudden cardiac death in patients with
coronary artery disease (1-3) . Even though the incidence of
clinical tachycardia is increased in these patients, it does not
occur in the majority . Because it is difficult to predict which
patients with coronary artery disease will develop sustained
tachyarrhythmias and might, therefore, benefit from antiar-
rhythmic therapy, treatment of these patients with drugs that
have associated adverse effects, including the potential for
exacerbating arrhythmias is controversial .
Electrophysiologic techniques have proved to be effica-
cious in managing patients who have sustained ventricular
tachycardia or have been resuscitated from sudden cardiac
death (4-10) . However, although the use of electrophysio-
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receive antiarrhythmic therapy . In the remaining 15 pa-
tients, arrhythmia management was not based on the
results of electrophysiologic testing . Only two episodes of
clinical sustained tachyarrhythmia occurred in the group
receiving electrophysiologically guided therapy compared
with seven episodes in the group treated without electro-
physiologic guidance (p < 0 .01) .
Thus, in patients with coronary artery disease with
nonsustained ventricular tachycardia on ambulatory elec-
trocardiography, electrophysiologic testing can identify
those at high and low risk for subsequent clinical tachycar-
dia events . Furthermore, results of such testing can be used
to optimize arrhythmia management in these patients .
(J Am Coll Cardiol 1 8 ;14 155-61)
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logic testing has been studied in patients with diverse cardiac
conditions and nonsustained ventricular tachycardia, there
are few data specifically concerning such testing in patients
with documented coronary artery disease . This study de-
scribes the use of electrophysiologic testing in patients with
asymptomatic nonsustained ventricular tachycardia and cor-
onary artery disease .
Methods
Study patients . The study group consisted of 40 men,
aged 44 to 71 years, with coronary artery disease who
underwent electrophysiologic testing after manifesting non-
sustained ventricular tachycardia of >5 beats' duration
during routine ambulatory electrocardiographic (ECG) mon-
itoring . Because nonsustained ventricular tachycardia fre-
quently occurs in such patients at the study institutions, we
excluded patients with runs of <5 beats in an effort to
maximize the specificity of electrophysiologic testing in this
group. Of 2,084 Holter ambulatory ECG recordings obtained
during a period of 20 months, 32% (667 recordings) mani-
fested ?3 beats of tachycardia ; 50 recordings had runs of >_5
beats .
Patients were also excluded from electrophysiologic test-
ing if 1) the tachycardia was polymorphic in configuration ; 2)
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there was a documented episode of syncope
; 3) the patient
had a history of sustained ventricular tachycardia or resus-
citation from sudden death in the absence of acute myocar-
dial infarction ; or 4) acute myocardial infarction had oc-
curred in the 2 weeks preceding the episode of nonsustained
tachycardia . No patient had decompensated congestive
heart failure, electrolyte or metabolic abnormalities or long
QT syndrome, which could contribute to arrhythmias . In all
40 patients, the nonsustained ventricular tachycardia was
detected in the absence of antiarrhythmic therapy ; the
arrhythmia was detected during routine evaluation of coro-
nary artery disease in 35 patients and during evaluation of
presyncope in 5 patients .
Documentation of coronary artery disease . This was doc-
umented by cardiac catheterization in 34 patients . The
remaining six patients had a history of acute myocardial
infarction documented by pathologic Q wave development
on the 12 lead ECG accompanied by elevation of the MB
fraction of creatine kinase . All patients underwent assess-
ment of ventricular function and wall motion by cardiac
catheterization or noninvasively by radionuclide or echocar-
diographic analysis . Angiographic coronary artery disease
was defined as ?50% reduction in luminal diameter in two
planes
. Of the 34 patients who underwent cardiac catheter-
ization, 5 had one vessel, 8 had two vessel and 21 had three
vessel coronary artery disease . Twenty-nine patients had
abnormal left ventricular function as judged by an ejection
fraction <50% ; 20 patients had a discrete region of dyskine-
sia or akinesia of the left ventricle on regional wall motion
analysis. Remote myocardial infarction had occurred in 33
patients, including 3 whose infarction had occurred within 4
weeks of the episode of nonsustained tachycardia .
ECG monitoring . The presence of nonsustained ventric-
ular tachycardia was documented on 24 hour ambulatory
ECG Hotter monitoring in 37 patients and during ambulatory
telemetric monitoring in 3 patients
. Complete Hotter monitor
data for arrhythmia frequency analysis were available for 3 
patients .
Follow-up
. End points for follow-up were the occurrence
of sustained ventricular tachycardia, sudden death, nonar-
rhythmic cardiac death and noncardiac death . In those
patients discharged on drug therapy guided by the results of
electrophysiologic testing, the occurrence of adverse effects
necessitating withdrawal of the drug resulted in that patient
being dropped from follow-up study at the time of drug
withdrawal .
Definitions .
Nonsustained ventricular tachycardia . For
inclusion in this study, patients had to have >5 beats of
monomorphic ventricular tachycardia at a rate > 120 beats/
min on ECG monitoring
; for the tachycardia to be consid-
ered nonsustained, it had to terminate spontaneously within
30 s. Patients with only polymorphic tachycardia were
excluded. On electrophysiologic testing, nonsustained ven-
tricular tachycardia was also defined as lasting for ~5
ventricular beats and <30 s . However, for quantitative
assessment of arrhythmia occurrence during Holter monitor-
ing, the Lown grading system was used and ventricular
tachycardia was defined as >_3 ventricular beats (Lown
grade 4b) .
Sustained ventricular tachycardia .
Sustained tachycardia
was defined as ventricular tachycardia lasting >30 s or
requiring termination in <30 s because of hemodynamic
deterioration .
Monomorphic tachycardia . The tachycardia was consid-
ered monomorphic in configuration if there was a single QRS
configuration and axis in each surface ECG lead .
Polymorphic tachycardia . The tachycardia was polymor-
phic if multiple QRS configurations with a constantly chang-
ing QRS axis were present in single ECG leads and the
polymorphic character persisted after the initial 6 beats of
the induced tachycardia.
Electrophysiologic testing protocol
. All electrophysiologic
studies were performed in the postabsorptive state ; for
baseline studies all antiarrhythmic medications were discon-
tinued for >_48 h. Electrocardiographic leads I, III and V I
and intracardiac electrograms from the atrioventricular junc-
tion and right ventricle were monitored and recorded on a
multichannel oscilloscope (Electronic for Medicine VR-12)
at paper speeds of 25 and 100 mm/s
. Right ventricular
stimulation was performed with use of a programmable
stimulator with an optically isolated constant current source
(Bloom Associates, Ltd
.) delivering rectangular pulses of 1
ms duration at twice diastolic threshold .
Premature extrastimulation was performed after eight
ventricular paced beats at two or three basic drive cycle
lengths, usually 600, 500 and 400 ms or 500 and 400 ms,
depending on the intrinsic heart rate . Single extrastimuli
were initially placed late in diastole, and diastole was then
scanned in 10 to 20 ms decrements until sustained ventricu-
lar tachycardia was induced or refractoriness was reached . If
tachycardia was not induced, double extrastimuli were then
delivered with S
2 placed 20 ms beyond the refractory period
and the S
2-S3 interval equal to the refractory period plus 50
ms . Then, S3 was decremented by 10 ms intervals until
refractoriness was reached, at which time S
2 was decre-
mented by 10 ms intervals to refractoriness
. The electrode
catheter was then positioned in the right ventricular outflow
tract where single and double extrastimuli were delivered
. If
ventricular tachycardia was not induced by single and dou-
ble extrastimuli at these two ventricular sites, triple extra-
stimuli were then delivered at both sites
. The end point of
the stimulation was induction of sustained monomorphic
ventricular tachycardia
. If the tachycardia was hemodynam-
ically stable, a second induction was performed
; if direct
current cardioversion was required for termination, a second
induction was not performed .
If ventricular tachycardia was induced, patients under-
went subsequent electrophysiologic testing of oral antiar-
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rhythmic agents   for these subsequent tests, electrode cath-
eters were removed after each study and new catheters were
inserted for each separate drug evaluation . During testing of
antiarrhythmic agents, a drug was defined as effective if <6
beats of tachycardia were induced with a stimulation proto-
col that either was identical to that of the control study or (if
only a single extrastimulus was required at control study)
included double premature stimuli . During drug testing,
stimulation was carried out at two ventricular sites for
efficacy. For amiodarone, efficacy was defined as either
noninducibility, as defined previously, or induction of
asymptomatic sustained tachycardia with a cycle length
>_ 100 ms longer than the baseline cycle length and hemody-
namic stability . Drug testing was performed after at least 5
half-lives and in the presence of therapeutic blood levels if
applicable . Testing on amiodarone was performed after 4 to
6 weeks of therapy and after a loading regimen of 1,400
mg/day for I week, then 1,000 mg/day for I week and 600
mg/day for 1 week, followed by 400 mg/day as a maintenance
dose .
Statistical analysis. Statistical analysis of data was per-
formed by two-tailed t test where appropriate . Event occur-
rence was analyzed by the life-table analysis method, with
chi-square testing for significance ; univariate and multivari-
ate analyses were performed with use of the log-rank test
and multiple logistic regression with chi-square testing for
significance . Statistical significance was defined as p < 0 .05 .
Results
Inducible tachycardia . Monomorphic ventricular tachy-
cardia was induced in 22 patients (Group I), and in 17 of
these 22, the tachycardia was sustained . Among these 17
patients, single ventricular extrastimuli were required for
induction in 2 patients, double extrastimuli in 8 and triple
extrastimuli in 6 ; in 1 patient, constant ventricular pacing to
determine stimulation threshold resulted in reproducible
tachycardia . The tachycardia was reproducibly induced in 12
patients ; 5 patients required direct current cardioversion
because of hemodynamic deterioration and the tachycardia
was not reinduced . Sustained polymorphic tachycardia or
ventricular fibrillation was not induced in any patient . Non-
sustained monomorphic tachycardia was reproducibly in-
duced in five patients ; in these five patients, the longest
nonsustained runs were 7, 11, 18, 24 and 30 beats, respec-
tively .
The remaining 18 patients did not have inducible mono-
morphic tachycardia (Group 11) .
In four of these patients,
nonsustained polymorphic tachycardia lasting 5 to 10 beats
was induced; these were considered nonclinical responses .
No tachycardia was inducible in 14 patients despite comple-
tion of the entire stimulation protocol . Three of the five
patients with presyncope had an episode of inducible tachy-
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Table 1. Clinical Characteristics of 40 Patients With Inducible
(Group I) and Noninducible (Group II) Ventricular Tachycardia
CAD = coronary artery disease   MI = myocardial infarction   NSVT =
nonsustained ventricular tachycardia   RP 500 = refractory period of the right
ventricle   VPB = ventricular premature beat .
cardia, only one of which was associated with hemodynam-
ically significant hypotension .
Clinical characteristics (Table 1) . By univariate analysis,
there were no differences between Groups I (inducible
tachycardia) and II (noninducible tachycardia) with respect
to age, extent of coronary disease, prior myocardial infarc-
tion or refractory period of the right ventricle . Patients in
Group I had significantly greater left ventricular dysfunction
as evidenced by a lower ejection fraction and a greater
prevalence of ventricular dyskinesia or akinesia . On Hotter
ECG monitoring, there were no differences between the
groups with respect to frequency of arrhythmias, either
simple hourly premature beats or runs of >_3 ventricular
beats per 24 h . The length of the longest run of ventricular
tachycardia was significantly greater among Group I pa-
tients, but there was a large degree of overlap between the
two groups .
Multivariate analysis was performed on these variables
by stepwise logistic regression .
By this analysis, the only
variable significantly associated with inducibility was the
presence of discrete ventricular dyskinesia or akinesia .
However, the presence or absence of akinesia or dyskinesia
was a poor screening test for inducibility or noninducibility
because the sensitivity and specificity were only 68% and
72%, respectively .
Treatment of tachycardia . Among the 22 Group I patients
with induced tachycardia, 16 underwent acute drug testing .
These included 13 with sustained and 3 with nonsustained
tachycardia . An effective drug by electrophysiologic testing
was found in 12 patients, and 11 were discharged on treat-
ment with this drug ; 1 patient with induced nonsustained
Group I
(n = 22)
Group 11
(n = 18) p Value
Age (yr) 60 ± 13 61 ± 7 NS
Extent of CAD NS
One vessel 3
Two vessel 3 5
Three vessel 12  
Prior MI 1  14 NS
Ejection fraction (Y) 31 ± 13 42 ± 14 <0.02
Akinesia or dyskinesia 15
4
<0 .01
RP 500 (ms) 248 ± 53 236 ± 55 NS
VPB/h 164 ± 158 216 ± 34  NS
Episodes of
NSVT/24 h (no
.)
Mean 33 ±   53 ±  7 NS
Range 1 to  3
1 to 314
Longest NSVT run (no . of beats)
Mean 8 ± 4 <0
.01
15 ± 10
Range
5 to 48 5 to 1 
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EPS inducible
n=22
EPS-directed
	
non-EPS directed
therapy therapy
n=11
n=11
NONSUSTAINED VENTRICULAR
TACHYCARDIA
N=40
VT/SCD
no VT/SCD VT/SCD no VT/SCD no VT/SCD
n=2 n= 
n=7 n=4 n=4
tachycardia refused therapy . Five patients were treated with
procainamide, four with quinidine, one with mexiletine and
one with amiodarone . An effective drug could not be iden-
tified in four patients, and all four were treated empirically
with amiodarone . Of the remaining six patients with induc-
ible tachycardia, five patients, including three who required
direct current cardioversion during the initial drug-free
study, refused further electrophysiologic testing and one
patient had a fatal cardiac arrest before drug therapy was
instituted . The five patients who refused further testing had
treatment guided by the results of Hotter monitoring .
For the 18 Group II patients with no inducible tachycar-
dia, including the 4 with polymorphic nonsustained tachy-
cardia, no treatment was recommended . Fourteen of these
18 patients were discharged without antiarrhythmic therapy,
whereas 2 were treated empirically and 2 guided by the
results of Hotter monitoring because of physician prefer-
ence. These four patients were treated with mexiletine,
procainamide, quinidine and tocainide, respectively . Thus,
long-term treatment of 25 of the total of 40 patients was
based on results of electrophysiologic testing .
Follow-up (Fig . 1) . After a follow-up period of 1 to 57
months (mean 14) for all 40 patients, there have been six
deaths, including five sudden deaths and one due to acute
myocardial infarction ; another 4 patients have had sponta-
neous sustained ventricular tachycardia that occurred after
hospital discharge. All five sudden deaths occurred in pa-
tients with inducible tachycardia, four with sustained and
one with nonsustained tachycardia . In four of these five
patients, therapy was not guided by the results of electro-
physiologic testing; the one patient with such therapy had
had nonsustained tachycardia of up to 24 beats induced at
EPS noninducible
n=18
empiric
therapy
n=4
no
therapy
n=14
no VT/SCD
n=14
baseline and was discharged on treatment with a drug that
allowed 5 repetitive ventricular responses by electrophysio-
logic testing . All four episodes of spontaneous sustained
ventricular tachycardia without sudden death also occurred
in patients with inducible sustained tachycardia, one of
whom had electrophysiologically guided therapy . This latter
patient had spontaneous stable ventricular tachycardia after
36 months of electrophysiologically defined procainamide
therapy .
Eight of the nine patients with either sudden death or
spontaneous sustained tachycardia had ventricular dyskine-
sia or akinesia . The mean cycle length of the tachycardia
induced at baseline drug-free electrophysiologic testing in
the 5 patients with sudden death was 248 ± 27 ms ; in the 4
patients with spontaneous sustained tachycardia, the base-
line cycle length was 348 ± 138 ms and in the remaining 13
patients of Group I without either end point, the baseline
cycle length was 272 ± 32 ms . These differences were not
statistically significant . Global ejection fraction among the
patients with sudden death was significantly lower than
among patients who had hemodynamically stable ventricular
tachycardia (0 .22 ± 0.03 versus 0 .40 ± 0.01, p < 0 .005) ;
however, there was no difference in ejection fraction be-
tween the patients with sustained tachycardia or sudden
death and those who had no sustained tachyarrhythmia
during follow-up study (0 .30 ± 0.12 versus 0.30 ± 0.13) .
Thus,   of the 22 patients in Group I had a clinical episode of
sustained ventricular tachycardia or fibrillation during the
follow-up period . In contrast, none of the 18 patients in
Group II, including the 4 with nonsustained polymorphic
tachycardia, have had a clinical tachyarrhythmic event (Fig .
2) . The difference in event rate between Groups I and II was
JACC Vol . 14, No . I
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Figure 1 . Flow diagram of outcome of 40 pa-
tients with either inducible or noninducible ven-
tricular tachycardia (VT) at electrophysiologic
study (EPS) . SCD = sudden cardiac death .
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Figure 2. Life-table analysis of the percent of 40 patients with
noninducible and inducible ventricular tachycardia who were free of
ventricular tachycardia or sudden death during the follow-up period .
significant (p < 0.01) .
For the entire study group of 40 patients . the use of
electrophysiologic testing to direct antiarrhythmic therapy
defined two groups of patients with significantly different
outcomes . The first group of 25 patients (Group III) con-
sisted of 14 patients who had no inducible ventricular
tachycardia and did not receive antiarrhythmic therapy plus
11 patients who had inducible tachycardia and received
therapy that was predicted to be effective by electrophysio-
logic testing . The second group (Group IV) included all 15
remaining patients ; in these patients, either no drug that
suppressed tachycardia could be found by testing or the
results were not used to select treatment . By life-table
analysis and chi-square testing, there was a significantly
lower event rate for ventricular tachycardia and sudden
death among Group I11 patients who received treatment
based on the results of electrophysiologic testing as com-
pared with the Group IV patients who did not (Fig . 3) . There
were no significant differences between Groups III and IV
with respect to age, number of diseased coronary arteries,
presence of prior infarction, ejection fraction, presence of
ventricular akinesia or dyskinesia or any Holter ECG mon-
itor variable ; the refractory period of the right ventricle was
shorter in the group with electrophysiologically directed
therapy (Table 2) .
Discussion
The results of this study indicate that electrophysiologic
testing of patients with coronary artery disease and nonsus-
tained ventricular tachycardia can be utilized to identify
those who are at risk for subsequent clinical sustained
ventricular tachycardia or sudden cardiac death . Our data
suggest that only those patients with inducible tachycardia
should be treated with antiarrhythmic therapy and that those
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ELECTROPILYSIOLOGY OF NONSUSTAINED TACHYCARDIA
1000
___1
0
P( .01
O-0 directed therapy (n=25)
	- •
non-directed therapy (n=15)
0 12
Time (months)
Figure 3 . Life-table analysis of patients with electrophysiologically
directed and nondirected therapy who were free of ventricular
tachycardia or sudden death during the follow-up period .
whose tachycardia is noninducible may not require treat-
ment regardless of Holter ECG findings . Patients who had
ventricular tachycardia induced by programmed stimulation
and in whom an effective drug could not be defined by repeat
electrophysiologic testing demonstrated a high incidence of
sustained ventricular tachycardia or cardiac arrest in the
follow-up period . Conversely, these clinical events did not
occur among the patients whose tachycardia was noninduc-
ible and who did not receive antiarrhythmic therapy .
Comparison with previous studies . Our results are consis-
tent with those from previous reports of electrophysiologic
testing in patients with nonsustained ventricular tachycar-
dia . Specifically, our findings support conclusions by Zheut-
Table 2. Clinical Characteristics of Patients Managed by
Electrophysiologically Directed (Group III) or Nondirected
(Group IV) Therapy
Abbreviations as in Table I
.
24
Group III
(n = 25)
Group IV
(n = 15) p Value
Age (yr)
62 ± 7 64 ± 8 NS
Extent of CAD NS
One vessel 16
6
Two vessel 6 3
Three vessel 2
4
Prior MI
22 12 NS
Ejection fraction (%) 36 ± 15 36
±
15 NS
Akinesia or dyskinesia 11
8 NS
RP 500 (ms) 248 ± 21 236 ± 16 <0 .05
VPB/h
214 ± 317 145 ± 156 NS
Episodes of NSVT/24 h (no .)
Mean
4  ± 84 22 ± 27 NS
Range 2 to 314
I to 77
Longest NSVT run (no . of beats)
Mean
NS
11 ± 5
14 ± 12
Range 5 to 21 5 to 48
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lin et al . (11) and Buxton et al. (12) that patients with clinical
nonsustained ventricular tachycardia that is not inducible by
programmed stimulation are at very low risk for ventricular
tachycardia or sudden death and may not require long-term
antiarrhythmic therapy . Furthermore, the data are consis-
tent with those of Buxton et al . (12), who found that therapy
that prevented the induction of tachycardia was associated
with a decreased incidence of sudden cardiac death and
sustained ventricular tachycardia .
Although our findings are consistent with previously
published data, it is important to note differences between
our study and previous studies . Buxton et al. (12) defined
nonsustained ventricular tachycardia as >3 repetitive mono-
morphic or polymorphic ventricular beats . This definition
differs from ours and may account for the infrequent induc-
tion of polymorphic tachycardia, especially sustained, in our
study as compared with the study by Buxton et al . (12) . Our
definition of clinical nonsustained ventricular tachycardia
also differed from that of other studies (11-15) . We used a
more restrictive definition of nonsustained ventricular tachy-
cardia because of the frequency of this arrhythmia in pa-
tients with coronary artery disease in our institutions . Fur-
thermore, because the role of electrophysiologic testing in
nonsustained ventricular tachycardia has been undefined,
we believed that we could maximize the specificity of the
electrophysiologic technique by excluding 3 and 4 beat runs
of this arrhythmia .
For the present study, the study group was homoge-
neous, consisting only of patients with documented coronary
artery disease . All previous reports (11,13-17) of electro-
physiologic testing for nonsustained ventricular tachycardia,
with the exception of the report by Buxton et al . (12), have
included patients with diverse cardiac diseases as well as
subjects without identifiable structural heart disease . Be-
cause it has been demonstrated that inducibility of tachycar-
dia in patients with clinical sustained ventricular tachycardia
is related to the presence or absence as well as the type of
cardiac disease (16,18), it is not surprising that inducibility in
patients with nonsustained tachycardia might depend on the
presence and type of underlying cardiac disease . By limiting
our study to patients with coronary artery disease, our
results are not influenced by subgroups of patients who
might have an inherently different incidence of tachycardia
induction . This might explain, at least in part, the frequency
with which monomorphic tachycardia was induced in our
study patients . We also found that patients who have induc-
ible tachycardia have more profound depression of ventric-
ular function, as measured by global ejection fraction. How-
ever, there was overlap between the two groups with respect
to ejection fraction, and the presence of ventricular akinesia
or dyskinesia was more highly correlated with inducibility,
suggesting the importance of discrete contraction abnormal-
ities and scar tissue as a substrate for sustained tachyar-
rhythmia. This is consistent with other studies (13,1 ) of
nonsustained as well as sustained tachycardia .
Of further interest was the high incidence of successful
drug therapy in the patients with inducible tachycardia . An
effective drug was found in 12 (75%) of the 16 patients
undergoing trials . This compares with a response rate of 50%
reported by Buxton et al . (12) . This difference is probably
related to differences in the patients selected for electrophys-
iologic testing, and suggests that the early identification of
these patients by electrophysiologic testing is important for
suppressive antiarrhythmic therapy .
Finally, the stimulation protocol used in this study in-
cluded up to three extrastimuli in all patients at two drive
cycle lengths and two ventricular sites . The optimal protocol
for electrophysiologic testing in these patients has not been
defined, and many previous studies used only 2 extrastimuli
in an effort to avoid nonspecific arrhythmias . In the present
study, ventricular tachycardia was induced only with triple
extrastimuli in nine patients and, thus, these patients would
have been missed by a protocol that included only double
extrastimuli . Furthermore, we considered induced polymor-
phic tachycardia to be nonclinical in this defined group of
patients and did not treat the four patients who had this
arrhythmia induced ; none of these four have had a clinical
event .
Limitations of the study . Therapy in this study was not
assigned in a controlled randomized fashion and, thus, the
true prognosis of patients with inducible but asymptomatic
clinical nonsustained ventricular tachycardia remains unde-
fined . In addition, because patients with 3 and 4 beat runs
were excluded, our findings cannot be applied to this very
large group of patients with coronary artery disease . Finally,
our results relate only to patients with coronary artery
disease and cannot be extrapolated to patients with other
forms of cardiac disease .
Clinical implications . Our findings support those of pre-
vious reports (11,12,17) in suggesting that electrophysiologic
testing of patients with nonsustained ventricular tachycardia
might identify those patients at low and high risk for subse-
quent development of sustained ventricular tachycardia or
sudden death . Thus, electrophysiologic testing could be
utilized to determine the need for antiarrhythmic therapy in
these patients ; our data support an electrophysiologically
defined approach to antiarrhythmic therapy .
We acknowledge the secretarial assistance of Deanna Adams
. Appreciation is
also extended to Betty Skipper, PhD for statistical support and to Gerald
Naccarelli, MD for critical review of the manuscript .
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